RRML - Involvement of inflammatory markers in pathogenesis of venous thromboembolism
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2016): 0.325

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- October 2017 -
 
Effect of long period treatment w... 6
Screening for common cystic fibro... 5
IL-6 gene polymorphisms and sepsi... 5
Association of ischemia-modified ... 5
Association of methionine synthas... 4
Epigenetic changes in myelodyspla... 4
Romanian Review of Laboratory Med... 4
Therapy-related myelodysplastic s... 4
Involvement of inflammatory marke... 4
Effects of low-molecular weight a... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 25(3)/2017 DOI:10.1515/rrlm-2017-0019
XML
TXT

Review

Involvement of inflammatory markers in pathogenesis of venous thromboembolism

Alexandra Florina Cocoi, Dana Pop, Mihai Cocoi, Adela Mihaela Serban, Luminita Animarie Vida-Simiti

Correspondence should be addressed to: Alexandra Florina Cocoi

Abstract

Inflammation of the venous wall is involved in thrombogenesis, thrombus resolution, wall remodeling and the post-thrombotic syndrome. Different mechanisms are involved in both arterial and venous thrombosis and patients with atherothrombosis hold a higher risk of venous thrombosis. Although inflammation may represent the connection between arterial and venous thrombosis, it is not yet sure if it is the cause or consequence of venous thrombosis. Consequently, the relationships between inflammation markers as indicators of the inflammatory process and clinical venous thromboembolism need to be investigated. For example, inflammation mediators such as the pro-inflammatory cytokines interleukin 8 (IL-8), IL-6, monocyte chemotactic protein 1 (MCP-1), C Reactive Protein (CRP), vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), matrix metalloproteinases and tumor necrosis factor alpha (TNF alpha) are all involved in thrombogenesis. Studies of venous thromboembolism on animal models proved that there are specific phases of the inflammatory process in venous thromboembolism and thrombus resolution. Knowing the molecular and immunologic mechanisms, identifying and understanding the inflammation markers which are relevant for venous thrombosis, can help to target specific pathways and to develop future therapies of this disease.

Keywords: thrombembolism, markers, inflammation, thrombus, venous thrombosis

Received: 21.2.2017
Accepted: 28.5.2017
Published: 10.7.2017

 
  PDF Download full text PDF
(327 KB)
     
 
How to cite
Cocoi AF, Pop D, Cocoi M, Serban AM, Vida-Simiti LA. Involvement of inflammatory markers in pathogenesis of venous thromboembolism. Rev Romana Med Lab. 2017;25(3):227-36. DOI:10.1515/rrlm-2017-0019